Archives

New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

B BOSTON, April 24, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient… Login to continue reading Login…

Read MoreNew Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

New Data Demonstrate Safety and Effectiveness of Bridge to Life’s VitaSmart Hypothermic Oxygenated Machine Perfusion (HOPE) System in Partial Graft Pediatric Liver Transplantation

B Study presented in oral session at the 30thAnnual Meeting of the Society of Pediatric Liver Transplantation (SPLIT), a section of The Transplantation Society (TTS)… Login to continue reading Login…

Read MoreNew Data Demonstrate Safety and Effectiveness of Bridge to Life’s VitaSmart Hypothermic Oxygenated Machine Perfusion (HOPE) System in Partial Graft Pediatric Liver Transplantation

FLAGSTAR BANK POSTS SECOND CONSECUTIVE QUARTER OF PROFITABILITY REPORTING FIRST QUARTER 2026 NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.03 PER DILUTED SHARE AND ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.04 PER DILUTED SHARE

B STRONG GROWTH IN C&I LENDING AS TOTAL C&I LOANS INCREASED $1.4 BILLION OR 9% COMPARED TO PRIOR QUARTER, WITH BROAD-BASED GROWTH CORE DEPOSITS, EXCLUDING… Login to continue reading Login…

Read MoreFLAGSTAR BANK POSTS SECOND CONSECUTIVE QUARTER OF PROFITABILITY REPORTING FIRST QUARTER 2026 NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.03 PER DILUTED SHARE AND ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS OF $0.04 PER DILUTED SHARE